BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20940723)

  • 21. Direct interaction between amphotericin B and ergosterol in lipid bilayers as revealed by 2H NMR spectroscopy.
    Matsumori N; Tahara K; Yamamoto H; Morooka A; Doi M; Oishi T; Murata M
    J Am Chem Soc; 2009 Aug; 131(33):11855-60. PubMed ID: 19645473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets.
    Neumann A; Baginski M; Czub J
    J Am Chem Soc; 2010 Dec; 132(51):18266-72. PubMed ID: 21126070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-tail interaction between amphotericin B and ergosterol occurs in hydrated phospholipid membrane.
    Umegawa Y; Nakagawa Y; Tahara K; Tsuchikawa H; Matsumori N; Oishi T; Murata M
    Biochemistry; 2012 Jan; 51(1):83-9. PubMed ID: 22129239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum.
    Corral MJ; González-Sánchez E; Cuquerella M; Alunda JM
    Antimicrob Agents Chemother; 2014; 58(3):1596-602. PubMed ID: 24366748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic fungicidal activities of polymyxin B and ionophores, and their dependence on direct disruptive action of polymyxin B on fungal vacuole.
    Ogita A; Konishi Y; Borjihan B; Fujita K; Tanaka T
    J Antibiot (Tokyo); 2009 Feb; 62(2):81-7. PubMed ID: 19132057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycosamine orientation of amphotericin B controlling interaction with ergosterol: sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge.
    Matsumori N; Sawada Y; Murata M
    J Am Chem Soc; 2005 Aug; 127(30):10667-75. PubMed ID: 16045354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large molecular assembly of amphotericin B formed in ergosterol-containing membrane evidenced by solid-state NMR of intramolecular bridged derivative.
    Matsumori N; Sawada Y; Murata M
    J Am Chem Soc; 2006 Sep; 128(36):11977-84. PubMed ID: 16953639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allicin-induced global gene expression profile of Saccharomyces cerevisiae.
    Yu L; Guo N; Meng R; Liu B; Tang X; Jin J; Cui Y; Deng X
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):219-29. PubMed ID: 20617313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vacuolar H+-ATPase subunit Vma1p functions as the molecular ligand in the vacuole-targeting fungicidal activity of polymyxin B.
    Iida M; Yamada K; Nango Y; Yamaguchi Y; Ogita A; Fujita KI; Tanaka T
    Microbiology (Reading); 2017 Apr; 163(4):531-540. PubMed ID: 28443813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.
    Vriens K; Kumar PT; Struyfs C; Cools TL; Spincemaille P; Kokalj T; Sampaio-Marques B; Ludovico P; Lammertyn J; Cammue BPA; Thevissen K
    Oxid Med Cell Longev; 2017; 2017():4064628. PubMed ID: 29129987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
    J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.
    Lewis RE; Wiederhold NP; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2006 Feb; 57(2):288-93. PubMed ID: 16387749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
    Geraghty P; Kavanagh K
    Arch Microbiol; 2003 Apr; 179(4):295-300. PubMed ID: 12640519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
    Makarasen A; Reukngam N; Khlaychan P; Chuysinuan P; Isobe M; Techasakul S
    J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium.
    Bolard J; Legrand P; Heitz F; Cybulska B
    Biochemistry; 1991 Jun; 30(23):5707-15. PubMed ID: 2043613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the antifungal properties of allicin and its breakdown products--the possibility of a safe and effective antifungal prophylactic.
    Davis SR
    Mycoses; 2005 Mar; 48(2):95-100. PubMed ID: 15743425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fungicidal activity of amphotericin B requires autophagy-dependent targeting to the vacuole under a nutrient-starved condition in Saccharomyces cerevisiae.
    Yoshioka M; Yamada K; Yamaguchi Y; Ogita A; Fujita KI; Tanaka T
    Microbiology (Reading); 2016 May; 162(5):848-854. PubMed ID: 26940206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity.
    Cybulska B; Gadomska I; Mazerski J; Borowski JGE ; Cheron M; Bolard J
    Acta Biochim Pol; 2000; 47(1):121-31. PubMed ID: 10961685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.